1
2
3
4
5
6
7
8
9
83rd OREGON LEGISLATIVE ASSEMBLY--2025 Regular Session
Senate Bill 289
Printed pursuant to Senate Interim Rule 213.28 by order of the President of the Senate in conformance with pre-
session filing rules, indicating neither advocacy nor opposition on the part of the President (at the request
of Senate Interim Committee on Health Care)
SUMMARY
The following summary is not prepared by the sponsors of the measure and is not a part of the body thereof subject
to consideration by the Legislative Assembly. It is an editor’s brief statement of the essential features of the
measure as introduced.The statement includes a measure digest written in compliance with applicable readability
standards.
Digest: The Act makes the State Board of Pharmacy study prescription drugs. (Flesch Read-
ability Score: 72.6).
Requires the State Board of Pharmacy to study prescription drugs. Directs the board to submit
findings to the interim committees of Legislative Assembly related to health care not later than
September 15, 2026.
Sunsets on January 2, 2027.
A BILL FOR AN ACT
Relating to prescription drugs.
Be It Enacted by the People of the State of Oregon:
SECTION 1. The State Board of Pharmacy shall study prescription drugs. The board shall
submit a report in the manner provided by ORS 192.245, and may include recommendations
for legislation, to the interim committees of the Legislative Assembly related to health care
no later than September 15, 2026.
SECTION 2.Section 1 of this 2025 Act is repealed on January 2, 2027.
NOTE:Matter in boldfaced type in an amended section is new; matter [italic and bracketed] is existing law to be omitted.
New sections are in boldfaced type.
LC 744